Research Article
Association of Preoperative Biliary Drainage with Postoperative Morbidity after Pancreaticoduodenectomy
Table 1
Clinical baseline characters of the patients with and without preoperative PBD.
| | | PBD () | No-PBD () | value |
| | Mean age (years) | 59 ± 2 | 57 ± 1 | 0.494 | | Male gender | 28 (59.6%) | 166 (57.6%) | 0.803 | | Hypertension | 8 (17.0%) | 50 (17.4%) | 0.954 | | Cardiovascular disease | 1 (2.1%) | 17 (5.9%) | 0.487 | | Diabetes mellitus | 3 (6.4%) | 28 (9.8%) | 0.594 | | Smoking pack-years (>20) | 14 (30.4%) | 94 (32.8%) | 0.755 | | White blood cells (×109/L) | 7.2 ± 0.5 | 6.6 ± 0.2 | 0.282 | | Hemoglobin (g/L) | 121.5 ± 2.7 | 119.6 ± 1.0 | 0.476 | | Platelet count (×109/L) | 201.3 ± 11.2 | 214.7 ± 5.0 | 0.311 | | Total bilirubin (μmol/L) | 363.2 ± 18.0 | 136.0 ± 8.4 | 0.001 | | Alanine aminotransferase (U/L) | 91.1 ± 11.8 | 95.7 ± 4.8 | 0.715 | | Aspartate aminotransferase (U/L) | 73.6 ± 8.0 | 81.4 ± 3.7 | 0.419 | | Albumin (g/L) | 38.3 ± 0.9 | 40.7 ± 2.6 | 0.710 | | Prothrombin time (s) | 12.9 ± 0.2 | 12.7 ± 0.1 | 0.500 | | Fibrinogen (g/L) | 4.1 ± 0.2 | 4.3 ± 0.1 | 0.250 | | Carcinoembryonic antigen (ng/mL) | 3.8 ± 0.4 | 5.7 ± 2.1 | 0.703 | | Carbohydrate antigen 125 (U/mL) | 19.6 ± 3.1 | 31.6 ± 6.2 | 0.398 | | Carbohydrate antigen 19-9 (U/mL) | 1062.5 ± 570.6 | 675.0 ± 203.2 | 0.471 | | Diameter of pancreatic duct (cm) | 0.6 ± 0.1 | 0.6 ± 0.2 | 0.772 | | Tumor diameter (cm) | 3.5 ± 0.2 | 4.3 ± 0.4 | 0.414 | | Diameter of common bile duct (cm) | 1.6 ± 0.1 | 1.7 ± 0.1 | 0.460 | | Blood loss (mL) | 463.8 ± 52.5 | 475.4 ± 33.5 | 0.893 | | Total expenditure (US dollars) | 10158.9 ± 1152.5 | 8889.1 ± 280.5 | 0.129 | | Pathological diagnosis | | | 0.881 | | Benign disease | 2 (4.3%) | 16 (5.6%) | | | Malignant carcinoma | 45 (95.7%) | 272 (94.4%) | | | Nutrient tube placement | 8 (17.0%) | 65 (22.6%) | 0.393 | | Combined vessel resection | 1 (2.1%) | 9 (3.1%) | 1.000 | | Hospital stay (days) | 25 | 21 | 0.350 |
|
|
PBD, preoperative biliary drainage.
|
